| Jubilant Pharmova Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530019 |
NSE Symbol : JUBLPHARMA |
P/E(TTM) : 207.40 |
|
ISIN Demat : INE700A01033 |
Div & Yield% : 0.54 |
EPS(TTM) : 4.45 |
|
Book Value(₹) : 145.16 |
Market Cap(₹Cr) : 14,702.59 |
Face Value(₹) : 1.00 |
| Particulars | Dec '26 | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 263.50 | 231.40 | 784.70 | 810.10 | 725.73 |
| Other Income | 45.70 | 20.20 | 103.40 | 137.90 | 126.16 |
| Stock Adjustments | 0.00 | 0.00 | -39.00 | -3.50 | 40.61 |
| Total Income | 309.20 | 251.60 | 849.10 | 944.50 | 892.50 |
| EXPENDITURE : | |||||
| Raw Materials | 0.00 | 0.00 | 316.50 | 411.10 | 372.89 |
| Power and Fuel Cost | 26.20 | 23.70 | 68.40 | 75.40 | 62.31 |
| Other Manufacturing Expenses | 25.60 | 22.80 | 59.60 | 49.00 | 39.80 |
| Selling and Administration Expenses | 55.40 | 48.60 | 88.60 | 93.00 | 111.59 |
| Miscellaneous Expenses | 12.40 | 6.50 | 6.10 | 7.70 | 9.65 |
| Employee Benefit Expenses | 103.80 | 92.10 | 190.00 | 167.30 | 163.64 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 85.80 | 57.90 | 119.90 | 141.00 | 132.62 |
| Interest | 7.30 | 12.90 | 29.90 | 18.50 | 10.99 |
| Gross Profit | 78.50 | 45.00 | 90.00 | 122.50 | 121.63 |
| Depreciation | 6.00 | 6.60 | 48.30 | 43.20 | 36.91 |
| Profit Before Tax | 72.50 | 38.40 | 41.70 | 79.30 | 84.72 |
| Current Tax | 4.60 | 20.50 | 6.80 | 13.80 | 14.28 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.70 | -1.30 | 3.30 | 15.60 | -10.05 |
| Reported Net Profit | 63.20 | 19.20 | 31.60 | 49.90 | 80.49 |
| Extraordinary Items | -7.64 | -3.00 | -0.76 | 0.25 | 0.02 |
| Adjusted Net Profit | 70.84 | 22.20 | 32.36 | 49.65 | 80.47 |
| Adjustment below Net Profit | 5.40 | 3.30 | 0.00 | -0.70 | 0.81 |
| Profit/Loss Balance carried down | 1,018.50 | 1,075.60 | 1,123.60 | 1,154.00 | 1,152.37 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 79.60 | 79.60 | 79.60 | 79.60 | 79.64 |
| P & L Balance carried down | 1,007.50 | 1,018.50 | 1,075.60 | 1,123.60 | 1,154.03 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Dividend Per Share(Rs) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Earnings Per Share-Unit Curr | 3.97 | 1.21 | 1.99 | 3.14 | 5.05 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 145.43 | 145.79 | 149.34 | 151.86 | 153.11 |
| Book Value(Adj)-Unit Curr | 145.43 | 145.79 | 149.34 | 151.86 | 153.11 |
